Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.1K citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +5

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.1K citations · Full text

Development and Validation of a Pediatric Crohnʼs Disease Activity Index

Jeffrey S. Hyams, George D. Ferry, Francine S. Mandel et al. · Journal of Pediatric Gastroenterology and Nutrition · 1991 · 964 citations

Development and validation of a pediatric Crohn's disease activity index.

Hyams Js, Ferry Gd, Mandel Fs et al. · PubMed · 1991 · 945 citations

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

David Knight, Han Trinh, Junming Le et al. · Molecular Immunology · 1993 · 710 citations

Autoimmune Disease, Allergy, Immunology +8